# Safety and Efficacy of Oral Versus Intravenous Amiodarone in the Treatment of AF

Study · id `cardio:ct-nct01817439` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01817439](<https://clinicaltrials.gov/study/NCT01817439>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01817439

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 104 participants.

## Technical summary

Registry record NCT01817439. Randomized; no masking; primary purpose treatment. Start 2013-05 (registry gives no type); primary completion 2015-05 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 104 participants (planned count; ClinicalTrials.gov record NCT01817439, source copy `cardio:ctgov-nct01817439-2013-03-25`, retrieved 2026-10-26)
- Start date: 2013-05 (registry gives no type) (ClinicalTrials.gov record NCT01817439, source copy `cardio:ctgov-nct01817439-2013-03-25`, retrieved 2026-10-26)
- Primary completion: 2015-05 (anticipated) (ClinicalTrials.gov record NCT01817439, source copy `cardio:ctgov-nct01817439-2013-03-25`, retrieved 2026-10-26)
- Completion: 2015-05 (anticipated) (ClinicalTrials.gov record NCT01817439, source copy `cardio:ctgov-nct01817439-2013-03-25`, retrieved 2026-10-26)
- Countries: Israel (ClinicalTrials.gov record NCT01817439, source copy `cardio:ctgov-nct01817439-2013-03-25`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01817439-2013-03-25`, retrieved 2026-10-26)

## The registry's words

- Brief title: Safety and Efficacy of Oral Versus Intravenous Amiodarone in the Treatment of AF
- Condition: Atrial Fibrillation
- Intervention (Drug): Amiodarone
- Lead sponsor: Western Galilee Hospital-Nahariya
- Lead sponsor class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry intervention name matches this record: Amiodarone (`cardio:amiodarone`)

## Provenance

Content hash: 7886df9d95c45265df9f465a0cede022adf5c4974e3f6fb84f4fcce641459395
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
